At Novartis, we reimagine medicine to improve and extend people’s lives. This includes discovering and developing breakthrough therapies, providing quality generics and biosimilars, and finding new ways to deliver these treatments to as many people as possible.
Products are listed alphabetically by brand name. This is not complete medical or product information. Click on the highlighted links next to the product names for complete prescribing information, including important safety information.
If you have a medical condition, promptly see your physician or other healthcare provider.
Showing 96 results
Gilenya® (fingolimod)(capsules, for oral use)
Gleevec® (imatinib mesylate)(tablets, for oral use)
Hycamtin® (topotecan)(capsules, for oral use)
Hycamtin® (topotecan)(for injection)
Ilaris® (canakinumab)(injection, for subcutaneous use)
Ilevro® (nepafenac ophthalmic suspension) 0.3%(topical ophthalmic)
Jadenu® (deferasirox)(tablets, for oral use)
Jadenu® Sprinkle (deferasirox)(granules, for oral use)
KESIMPTA® (ofatumumab)(injection, for subcutaneous use)
Kisqali® Femara® Co-Pack (ribociclib tablets; letrozole tablets)(co-packaged for oral use)